Moreover, obesity may cause insulin resistance with hyperinsulinemia, further leading to an increase in insulin-like growth factor-1 which then promotes proliferation and inhibits apoptosis through receptor-mediated pathways, resulting in hepatic carcinogenesis (49). Here, IGF1 is linked to obesity disorder.